Benitec Biopharma
BNTC
BNTC
3 hedge funds and large institutions have $55K invested in Benitec Biopharma in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$10K |
| 2 |
2
Bank of America
Charlotte,
North Carolina
|
$6K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
WS
1
Wedbush Securities
Los Angeles,
California
| $39K | 18,197 | -8,753 | -32% |
|
|
2
UBS Group
Zurich,
Switzerland
| $10K | 4,358 | +2,900 | +199% |
|
|
3
Bank of America
Charlotte,
North Carolina
| $6K | 2,600 | +2,600 | New |
|
|
AIM
4
Acrospire Investment Management
Chicago,
Illinois
| – | – | -7,217 | Closed |
|
5
Acadian Asset Management
Boston,
Massachusetts
| – | – | -4,159 | Closed |
|
6
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | – | -1,000 | Closed |
|